Most Popular Articles

August 2022

  1. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
  2. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
  3. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
  4. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
  5. Is Caffeine a Cognitive Enhancer?
  6. Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1
  7. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
  8. The Dark Side of Alzheimer’s Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level
  9. Air Pollution and Dementia: A Systematic Review
  10. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options

July 2022

  1. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
  2. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
  3. Automated Early Detection of Alzheimer’s Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks
  4. Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging
  5. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
  6. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
  7. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
  8. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
  9. Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions
  10. Air Pollution and Dementia: A Systematic Review

June 2022

  1. Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
  2. Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
  3. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
  4. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
  5. Is Caffeine a Cognitive Enhancer?
  6. Caffeine and Adenosine
  7. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
  8. Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
  9. A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging
  10. Caffeine, Mental Health, and Psychiatric Disorders

May 2022

  1. Is Caffeine a Cognitive Enhancer?
  2. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
  3. Caffeine, Mental Health, and Psychiatric Disorders
  4. Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
  5. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
  6. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
  7. Caffeine and Adenosine
  8. Neurobiology of COVID-19
  9. Impact of Social Isolation on People with Dementia and Their Family Caregivers
  10. Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis

April 2022

  1. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
  2. Is Caffeine a Cognitive Enhancer?
  3. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
  4. Caffeine and Adenosine
  5. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
  6. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
  7. Making the Case for Accelerated Withdrawal of Aducanumab
  8. Caffeine, Mental Health, and Psychiatric Disorders
  9. Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
  10. Neurobiology of COVID-19

March 2022

  1. Is Caffeine a Cognitive Enhancer?
  2. Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
  3. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
  4. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
  5. Caffeine and Adenosine
  6. Caffeine, Mental Health, and Psychiatric Disorders
  7. Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
  8. Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
  9. Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early AD
  10. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial

February 2022

  1. Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer’s Disease in the Absence of Memantine
  2. Is Caffeine a Cognitive Enhancer?
  3. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
  4. Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
  5. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
  6. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer’s Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial
  7. Caffeine, Mental Health, and Psychiatric Disorders
  8. Caffeine and Adenosine
  9. Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
  10. Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial

January 2022

  1. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
  2. Is Caffeine a Cognitive Enhancer?
  3. Neurobiology of COVID-19
  4. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
  5. Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
  6. Caffeine and Adenosine
  7. The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
  8. COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
  9. Air Pollution and Dementia: A Systematic Review
  10. Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer’s Disease: A Systematic Review